SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice.
Kimura M, Kawahito Y, Hamaguchi M, Nakamura T, Okamoto M, Matsumoto Y, Endo H, Yamamoto A, Ishino H, Wada M, Omoto A, Tsubouchi Y, Kohno M, Yoshikawa T.
Kimura M, et al. Among authors: kawahito y.
Biomed Pharmacother. 2007 May;61(4):222-8. doi: 10.1016/j.biopha.2006.10.002. Epub 2006 Nov 14.
Biomed Pharmacother. 2007.
PMID: 17147981